跳至主要内容
临床试验/ISRCTN64997989
ISRCTN64997989进行中(未招募)Unknown

Establishing the burden of vaccine-preventable acute lower respiratory tract infections in primary care, UK

niversity of Bristol0 个研究点目标入组 2,700 人开始时间: 2024年4月4日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
2,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged =18 years of age; AND
  • 2. Presenting to primary care with acute illness (i.e., present for 28 days or less); AND
  • 3. Evidence of aLRTD* as guided by the following criteria:
  • 3.1. Evidence of aLRTI (including acute bronchitis, pneumonia and infective exacerbations of chronic lung disease):
  • 3.1.1. Clinical suspicion of LRTI and new/worsened cough with one or more of the following signs/symptoms: sputum production or purulence, chest pain, wheeze, shortness of breath, tachypnoea or abnormal auscultatory findings suggestive of aLRTI; OR
  • 3.1.2. Clinical diagnosis of aLRTI OR
  • 3.2. Evidence of acute exacerbation of pre-existing heart failure with respiratory symptoms:
  • 3.2.1. Clinical suspicion of acute exacerbation of pre-existing heart failure and new or worsening of two or more of the following signs/symptoms: cough (including nocturnal cough), shortness of breath, wheeze, tachypnoea, abnormal auscultatory findings suggestive of exacerbation of heart failure; OR
  • 3.2.2. Clinical diagnosis of acute exacerbation of heart failure with respiratory symptoms OR
  • 3.3. Evidence of non-infective exacerbation of pre-existing chronic lung disease:
  • 3.3.1. Clinical suspicion of presumed non-infective exacerbation of pre-existing chronic lung disease and new or worsening of two or more of cough, shortness of breath, wheeze, tachypnea, abnormal auscultatory findings suggestive of acute non-infective exacerbation; OR
  • 3.3.2. Clinical diagnosis of non-infective exacerbation
  • *Acute lower respiratory tract disease (aLRTD) includes acute lower respiratory tract infection (aLRTI) and its subgroups, acute exacerbation of pre-existing heart failure and presumed non-infective exacerbation of chronic lung disease.

排除标准

  • 1. Previously enrolled participants within 28 days of the onset of the study qualifying aLRTD illness
  • 2. At the time of enrolment, alternative non-LRTD working diagnosis suspected
  • 3. Presenting to primary care with the same episode of aLRTD for which they have been discharged from hospital
  • 4. Any patient who develops signs and symptoms of LRTD after being hospitalized for =48 hours

研究者

发起方
niversity of Bristol

相似试验